Search

You searched for "Benign"

262 results found

DUS Annual Meeting 2025 – a story from Nyborg Strand

1 May 2026 | Urology News
13–15 November 2025 / Funen, Denmark Naomi Nadler, Urology Resident; Rose Laursen, Urology Resident; and Stine Hedegaard, Consultant Urologist, Department of Urology, Zealand University Hospital, Roskilde, Denmark. Every November, the urological community of Denmark migrates to the central island Funen...

Lasers in urology

3 July 2026 | | URO - Technology
1. What does LASER stand for? 2. What elements are involved and how is a LASER created? 3. The following cases involve laser surgery. Can you diagnose the pathology, identify which type of lasers can be used, and their wavelengths?...

Purple urine bag syndrome

1 July 2021 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
Purple urine bag syndrome (PUBS) is an uncommon phenomenon where the tubing and urinary catheter bag is noticed to undergo purple discolouration. This has been linked with urinary tract infections (UTI), chronic debilitated states and prolonged catheterisation. PUBS was noticed...

Mechanisms and prevention of catheterisation associated urethral injury (CAUI)

5 November 2019 | | URO - Neurourology, URO - Infection, URO - Functional / Reconstructive Urology, URO - Technology
Urethral catheterisation is a common procedure performed by health professionals across different grades and specialties in a variety of clinical settings. An estimated 15-25% of hospitalised patients have a urinary catheter inserted during their inpatient stay and up to 13%...

Renal oncocytoma: Diagnosis and surveillance strategy

7 May 2026 | | URO - Urologic Oncology, URO - Uroradiology
Renal oncocytoma is one of the most common benign renal neoplasms, accounting for around 3–7% of all renal tumours, and up to 18% of all small renal masses (SRMs) measuring less than 4cm [1, 2]. Most oncocytomas are asymptomatic and...

Biomarkers in prostate cancer detection

1 July 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
Prostate cancer (PCa) is the second most common cancer in men with an estimated prevalence of 1.1 million worldwide in 2012. This heterogeneous disease resulted in approximately 307,000 deaths, making it the fifth leading cause of cancer-related death in men...

My UK reconstructive urology fellowship experience

8 November 2021 | | URO - Andrology, URO - Functional / Reconstructive Urology
Surgical training is a long and hard pathway. Having completed medical school, I undertook my internship at the Alfred Hospital in Melbourne. The Alfred Hospital is a leading tertiary teaching hospital in Australia’s second largest city. Prior to commencing my...

Modern management of small renal masses

1 September 2019 | | URO - Urologic Oncology
With the advent of widespread cross-sectional imaging there has been a surge in incidental detection of small renal masses (SRMs) and renal cell carcinoma (RCC) is now the seventh most common cancer in the UK. Whilst surgical excision for larger...

Testicular microlithiasis

1 May 2015 | | URO - Urologic Oncology, URO - Uroradiology
Introduction Testicular microlithiasis (TML) was originally described in 1970 in a healthy four-year-old boy [1] and the first paper regarding microlithiasis as an entity seen on ultrasound was published in 1987 [2]. Testicular microlithiasis is seen on ultrasound as small,...

Focal therapy trials

6 November 2020 | | URO - Urologic Oncology
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer...

EAU Guidelines App

1 July 2017 | | URO - Technology
The European Association of Urology (EAU) continues to lead on the latest guidelines within urology. The all new EAU guidelines app brings together the pocket version of the EAU guidelines with a much improved user interface. Both the cancer and...

Use of MRI in the evaluation of prostate cancer: part 1

1 January 2015 | | URO - Urologic Oncology, URO - Uroradiology
Introduction Prostate cancer remains the most commonly diagnosed cancer in males and the second leading cause of cancer related deaths in UK men, after lung cancer [1]. The incidence of prostate cancer in the UK has shown a rapid increase...